Navigation Links
Abaxis to Report First Quarter Fiscal Year 2014 Financial Results Thursday, July 25, 2013
Date:7/16/2013

UNION CITY, Calif., July 16, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter fiscal year 2014, ended June 30, 2013. The call will be at 4:15 p.m. ET on Thursday, July 25, 2013.  The Company will report financial results for the first quarter fiscal year 2014 after the market closes on Thursday, July 25, 2013.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10031352, through August 1, 2013.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.Contact:

Clint Severson

Lytham Partners, LLCChief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum Abaxis, Inc.

602-889-9700 510-675-6500
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis, Inc. to Present at the Jefferies 2013 Global Healthcare Conference
2. Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference
3. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
4. Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013
5. Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
6. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
7. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
8. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
9. Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013
10. Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013
11. Abaxis Declares Special Cash Dividend of $1.00 Per Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)... WHIPPANY, N.J. , July 11, 2017  Bayer has ... across eight countries as part of its prestigious Bayer Hemophilia ... Children,s Hospital of Philadelphia and Uniformed ... are among the winners. Grant recipients were announced ... Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, ... urinalysis diagnostic testing equipment as well as middleware ... a way to make quality assurance easier and ... "Sysmex is well known for the innovation that ... Quality Monitor elevates quality assurance processes to a ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... A July 5th article on Reuters Health News discusses a ... body contouring procedure reported experiencing a better quality of life, compared to other patients. ... types of procedures, notes that this report jibes with what they regularly hear from ...
(Date:7/20/2017)... , ... July 20, 2017 , ... “Lucky the Buffalo and Her Adventures”: a collection ... published author, Edward Bieniek. Edward Steven Bieniek Jr. was born in Toledo, Ohio. ... Toledo at com tech. He is married to a brilliant woman with a caring ...
(Date:7/18/2017)... ... 18, 2017 , ... ClinicalTrials.gov and the New Final Rule ... Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. – 3:00 p.m. ... Clinical Trials Registration and Results Information,” is a head-scratcher. After reading and re-reading ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, Wash., knows the ... I have frequent hot flashes, and I suffer from anxiety and vertigo on top ... cool while out and about." INSTA-FAN meets that need. , This device enables a ...
(Date:7/18/2017)... (PRWEB) , ... July 19, 2017 , ... ... Winner for it’s Corporate Social Responsibility Initiative in the prestigious CEO World Awards®. ... leadership, innovation, organizational performance, new products and services, CEO case studies, corporate social ...
Breaking Medicine News(10 mins):